MedPath

A Pilot Randomized Controlled Trial to Reduce Salt Intake Among Hypertensive Young Adults in Hong Kong

Not Applicable
Terminated
Conditions
Hypertension
Registration Number
NCT02920437
Lead Sponsor
The University of Hong Kong
Brief Summary

A pilot randomized controlled trial will be conducted to investigate the feasibility and effectiveness of a salt intake reduction intervention to young hypertension patients in Hong Kong who had high salt intake.

Detailed Description

Convenience sample will be recruited from the community in Hong Kong through different channels of promotion.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
19
Inclusion Criteria
  • i) adults aged 18 to 44
  • ii) diagnosed hypertension or borderline hypertension
  • iii) complete collection of 24-hour urine at baseline
  • iv) 24-hour urinary sodium excretion above 2000mg at baseline
  • v) can communicate in Cantonese
Exclusion Criteria
  • i) renal illnesses;
  • ii) taking diuretics;
  • iii) taking RAS blockers;
  • iv) attending or planning to attend new hypertension education programme or salt intake reduction programme during the study period.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
24-hour urinary sodium excretion10-Week

Difference between the intervention and control group in the change in 24-hour urinary sodium excretion from baseline to the end of follow-up

Secondary Outcome Measures
NameTimeMethod
Health literacy on low salt intake10-Week

Difference between the intervention and control group in the change in health literacy on low salt intake measured with the validated Chinese Health Literacy Scale for Low Salt Consumption (CHLSalt-HK)

Trial Locations

Locations (1)

School of Nursing, The University of Hong Kong

🇨🇳

Hong Kong, China

School of Nursing, The University of Hong Kong
🇨🇳Hong Kong, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.